Top Markets
Coin of the day
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.

HEPA
Pozycja w akcjach #38693
Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is... Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cyclophilin inhibitor that has successfully concluded Phase 2a clinical trials. This compound operates by disrupting multiple pathological pathways implicated in the worsening of liver disease. It is currently progressing through clinical development for non-alcoholic steatohepatitis (NASH) and is additionally being explored in nonclinical research for its potential to reduce liver fibrosis and lessen hepatocellular carcinoma tumor loads in experimental models of NASH. Moreover, Rencofilstat has exhibited antiviral properties against hepatitis B, C, and D viruses through diverse mechanisms. The company, established in 2013 and situated in Edison, New Jersey, rebranded as Hepion Pharmaceuticals, Inc. in July 2019, having previously operated as ContraVir Pharmaceuticals, Inc.
Cena akcji
$0.073
Kapitalizacja rynkowa
$849.99K
Zmiana (1 dzień)
4.29%
Zmiana (1 rok)
21.67%
Kraj
US
Handel Hepion Pharmaceuticals, Inc. (HEPA)

Kategoria

Historia podziałów akcji dla Hepion Pharmaceuticals, Inc. (HEPA)
Akcje Hepion Pharmaceuticals, Inc. (symbol: HEPA) przeszły łącznie 0 podziałów.
Najnowszy podział miał miejsce Aug 14, 2026.
Jedna akcja HEPA kupiona przed Aug 14, 2026 odpowiada dziś 0 akcjom HEPA.
Lista podziałów akcji
Rok Podział Mnożnik Skumulowany mnożnik
Za mało danych dla podanych dat.
Podziały akcji dla podobnych firm lub konkurencji
Firma Liczba podziałów akcji Skumulowany mnożnik Kraj
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE